Biopharmaceutical company.
P.L. 114-113: "Consolidated Appropriations Act of 2015" as it relates to increased appropriations for Viral Hepatitis Testing for VA and reauthorization of the rare disease pediatric review voucher program.

Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars.

H.R. 6: 21st Century Cures Act.

Education about the value of innovative new medicines.

Education about the 340(b) program. Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program. P.L. 114-74: Bipartisan Budget Act of 2015.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX